Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Capristano

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Revista Peruana De Medicina Experimental Y Salud Publica|June 11, 2020
Differential expression of circulating micro-RNAs in patients with active and latent tuberculosisJosé Yareta, Marco Galarza, Silvia Capristano, et al.
Microorganisms|June 28, 2023
Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis InfectionCesar Sanchez, Luis Jaramillo-Valverde, Silvia Capristano, et al.
Pharmacology Research & Perspectives|April 26, 2024
Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populationsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Cureus|February 3, 2022
CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell MigrationLuis Jaramillo-Valverde, Kelly S Levano, Silvia Capristano, et al.
Frontiers in Cellular and Infection Microbiology|July 18, 2022
Comparative Profiling of Circulating Exosomal Small RNAs Derived From Peruvian Patients With Tuberculosis and Pulmonary AdenocarcinomaHeinner Guio, Victor Aliaga-Tobar, Marco Galarza, et al.
Pathogens (Basel, Switzerland)|December 31, 2025
IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, PeruNawal De la Peña Galindo, Silvia Capristano Valdez, Cesar Sanchez Neira, et al.
International Journal of Molecular Sciences|October 14, 2022
<i>GSTT1/GSTM1</i> Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian PatientsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Molecular Genetics & Genomic Medicine|June 25, 2022
NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patientsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|November 22, 2023
Neutralization of SARS-CoV-2 (lineage B.1.1) by hyperimmune llama (Lama glama) serum in vero cell cultureVerónica Yaniro, Silvia Capristano, Henri Bailon, et al.
Molecular Genetics & Genomic Medicine|September 12, 2021
Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patientsKelly S Levano, Luis Jaramillo-Valverde, David D Tarazona, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Revista Peruana De Medicina Experimental Y Salud Publica|June 11, 2020
Differential expression of circulating micro-RNAs in patients with active and latent tuberculosisJosé Yareta, Marco Galarza, Silvia Capristano, et al.
Microorganisms|June 28, 2023
Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis InfectionCesar Sanchez, Luis Jaramillo-Valverde, Silvia Capristano, et al.
Pharmacology Research & Perspectives|April 26, 2024
Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populationsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Cureus|February 3, 2022
CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell MigrationLuis Jaramillo-Valverde, Kelly S Levano, Silvia Capristano, et al.
Frontiers in Cellular and Infection Microbiology|July 18, 2022
Comparative Profiling of Circulating Exosomal Small RNAs Derived From Peruvian Patients With Tuberculosis and Pulmonary AdenocarcinomaHeinner Guio, Victor Aliaga-Tobar, Marco Galarza, et al.
Pathogens (Basel, Switzerland)|December 31, 2025
IL-5 and IP-10 Detected in Quantiferon Supernatants Distinguish Latent Tuberculosis from Healthy Individuals in Areas with High Burden in Lima, PeruNawal De la Peña Galindo, Silvia Capristano Valdez, Cesar Sanchez Neira, et al.
International Journal of Molecular Sciences|October 14, 2022
<i>GSTT1/GSTM1</i> Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian PatientsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Molecular Genetics & Genomic Medicine|June 25, 2022
NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patientsLuis Jaramillo-Valverde, Kelly S Levano, David D Tarazona, et al.
Revista Peruana De Medicina Experimental Y Salud Publica|November 22, 2023
Neutralization of SARS-CoV-2 (lineage B.1.1) by hyperimmune llama (Lama glama) serum in vero cell cultureVerónica Yaniro, Silvia Capristano, Henri Bailon, et al.
Molecular Genetics & Genomic Medicine|September 12, 2021
Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patientsKelly S Levano, Luis Jaramillo-Valverde, David D Tarazona, et al.
Pageof 2